This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Joon Kyum Kim: Innovator in Antineoplastic Compounds
Introduction
Joon Kyum Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of camptothecin compounds. With a total of 2 patents, his work focuses on enhancing the efficacy of antineoplastic agents.
Latest Patents
Among his latest patents are innovative methods related to camptothecin compounds. One patent details the preparation of camptothecin derivatives and their pharmaceutically acceptable salts. These derivatives are modified in the B-ring and E-ring, resulting in improved water solubility and enhanced antineoplastic effects. Another patent involves intermediates for the synthesis of these camptothecin derivatives, showcasing his expertise in pharmaceutical chemistry.
Career Highlights
Joon Kyum Kim is associated with Chong Kun Dang Corporation, a leading pharmaceutical company in South Korea. His work at the company has been instrumental in advancing cancer treatment options through the development of novel compounds.
Collaborations
He has collaborated with notable colleagues, including Sang Sup Jew and Hee Soon Lee, contributing to a dynamic research environment that fosters innovation.
Conclusion
Joon Kyum Kim's contributions to the field of pharmaceuticals, particularly in the development of camptothecin derivatives, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment.